ERBB2 and breast carcinoma: The MCF-7 cell line was critically important to the development of the hormonal therapies used to treat patients with estrogen-receptor positive breast cancer13–16, as were breast cancer cell lines with HER2 amplifications for the development of HER2-targeted drugs17–24.